Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Amneal Pharmaceuticals
AMRX
$6.32B
| $6.76M | ﹤0.01% |
1,479,924
+172,597
| +13% | +$765K |
|
3052
PUT
Ambarella
AMBA
$3.6B
| $6.76M | ﹤0.01% |
73,600
-41,400
| -36% | -$2.9M |
|
3053
CALL
iShares Russell 1000 Value ETF
IWD
$84.2B
| $6.75M | ﹤0.01% |
49,400
+44,900
| +998% | +$5.76M |
|
|
TRTN
3054
DELISTED
Triton International Limited
TRTN
| $6.75M | ﹤0.01% |
139,198
+8,552
| +7% | +$362K |
|
3055
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.48B
| $6.74M | ﹤0.01% |
91,816
+31,387
| +52% | +$2.21M |
|
3056
CALL
Boyd Gaming
BYD
$6.11B
| $6.74M | ﹤0.01% |
157,000
-36,400
| -19% | -$1.34M |
|
3057
CALL
Olin
OLN
$2.18B
| $6.74M | ﹤0.01% |
274,300
+122,500
| +81% | +$2.49M |
|
3058
PUT
Avis
CAR
$4.87B
| $6.74M | ﹤0.01% |
180,600
-223,600
| -55% | -$7.86M |
|
3059
CALL
Sonos
SONO
$1.93B
| $6.73M | ﹤0.01% |
287,700
-4,600
| -2% | -$85.8K |
|
3060
CALL
Northern Trust
NTRS
$35B
| $6.72M | ﹤0.01% |
72,200
+20,400
| +39% | +$1.8M |
|
|
PE
3061
PUT
DELISTED
PARSLEY ENERGY INC
PE
| $6.72M | ﹤0.01% |
473,400
-220,300
| -32% | -$2.62M |
|
3062
PUT
Global X Silver Miners ETF NEW
SIL
$4.79B
| $6.71M | ﹤0.01% |
147,200
+78,700
| +115% | +$3.44M |
|
|
AZUL
3063
DELISTED
Azul
AZUL
| $6.71M | ﹤0.01% |
294,196
+244,896
| +497% | +$4.39M |
|
3064
Inspire Medical Systems
INSP
$1.65B
| $6.71M | ﹤0.01% |
35,666
+11,588
| +48% | +$1.89M |
|
|
TTM
3065
DELISTED
Tata Motors Limited
TTM
| $6.71M | ﹤0.01% |
532,440
-179,739
| -25% | -$1.92M |
|
|
OPTU
3066
Optimum Communications Inc
OPTU
$251M
| $6.7M | ﹤0.01% |
176,968
-8,408,221
| -98% | -$263M |
|
3067
Xylem
XYL
$27.9B
| $6.7M | ﹤0.01% |
65,823
-80,809
| -55% | -$7.6M |
|
|
GBT
3068
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $6.7M | ﹤0.01% |
154,700
+68,200
| +79% | +$3.36M |
|
|
MIME
3069
DELISTED
Mimecast Limited
MIME
| $6.7M | ﹤0.01% |
117,814
+64,419
| +121% | +$2.98M |
|
3070
iShares MSCI Singapore ETF
EWS
$1.17B
| $6.68M | ﹤0.01% |
310,904
+226,461
| +268% | +$4.61M |
|
3071
Scholar Rock
SRRK
$6.4B
| $6.67M | ﹤0.01% |
137,466
+53,859
| +64% | +$1.96M |
|
3072
Legend Biotech
LEGN
$3.95B
| $6.66M | ﹤0.01% |
236,649
-68,527
| -22% | -$1.97M |
|
3073
iShares Global 100 ETF
IOO
$9.42B
| $6.66M | ﹤0.01% |
+105,920
| New | +$6.3M |
|
3074
CALL
Dycom Industries
DY
$12.6B
| $6.66M | ﹤0.01% |
88,200
+55,500
| +170% | +$3.83M |
|
3075
CALL
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.32B
| $6.65M | ﹤0.01% |
61,014
+11,214
| +23% | +$1.2M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.